课题基金 / 基金详情

项目摘要

项目成果

Raju Metherate的其他基金

相似基金

相关文献

中文摘要
翻译
P30的主任将是Raju Metherate博士。Dr. Metherate也是一个 这是有利的布置,因为P30和P20之间的紧密关系将最大化P30和P20之间的相互作用。 两组的有效性。Metherate博士是该组织的创始成员和副主任。 IRU听力和言语科学,并承担了IRU的活动在2003年的责任,当博士。 Len Kitzes成为解剖学和神经生物学系的代理主任。当IRU 2005年过渡到妇女地位委员会,Metherate博士当选为主任。Metherate博士加入UCI作为一个 1995年任助理教授,现任系副教授。神经生物学和 行为他是PI的两个NIH R 01赠款,从NIDCD和NIDA,并保持连续 在NIH和NSF的资助下,他研究了听觉皮层的细胞机制超过13年。 由于学校是UCI的“校园中心”,其主任直接向自己的院长(生物学)报告。 科学)和副校长的研究,从其办公室的任务和资金, 起源。与研究副校长的沟通渠道很重要,因为 P30和P30涉及UCI校园内五所学校的十一个部门的教师。的 P30和P20的行政结构是这样的,没有一个部门承担不适当的重量, 影响力的社会(See附录为P30教师及其部门和学校附属机构的列表。 P30执行委员会将由主任、两名核心主任和一名轮值主席组成。 P30研究人员的代表。请注意,核心董事来自不同的学校 (生物科学与医学)。执行委员会将定期举行会议,至少每季度一次, 确保每个核心及其用户的需求得到满足,并确保所有设施得到管理 有效地核心主管可以在每个核心用户的内部会议上提出问题 和咨询委员会。此外,执行委员会作为一个小组将征求和评估 定期(至少每年一次)收到所有用户的反馈,并向 负责P30程序和优先事项的变更。重要的问题将包括P30如何 能够加强正在进行的研究,促进跨学科合作。 请注意,每个核心主任,在与核心的咨询委员会协商,将负责 优先使用他或她的核心。一般而言,使用核心设施的最高优先级为 为正在进行的、由R 01资助的与NIDCD有关的研究提供支持。第二优先事项将是 由其他联邦资助的研究(例如,NIH-R03,NSF)。其他优先事项(例如, 吸引新的调查人员研究与非传染性疾病相关的专题)。适当 执行委员会将每季度审查每个核心的资源分配情况, 会议和程序,以解决不公平的制定。 P30的行政支持将通过Dr. Metherate的家庭部门提供, 部神经生物学和行为(主席,博士托马斯J.卡鲁)。部门工作人员将协助 人事、采购、安排会议、编写进度报告和其他行政 任务该部门熟悉跨学科研究中心的需求, 与三个主要的研究机构由系教师指导的关系:中心的 学习和记忆的神经生物学(Michael D.脑老化研究所(Institute for Brain Aging) 和痴呆症(卡尔W。科特曼,主任),和里夫-欧文研究中心(博士奥斯瓦德 管理员、主任)。预计P30的管理工作量最小: 主任和核心主任,和25%的努力,行政助理在该部。的 神经生物学和行为。
英文摘要
The Director of the P30 will be Dr. Raju Metherate. Dr. Metherate also is Director of CHR, an advantageous arrangement since a close relationship between the P30 and CHR will maximize the effectiveness of both groups. Dr. Metherate was a founding member and Associate Director of the IRU for Hearing and Speech Science, and assumed responsibility for IRU activities in 2003 when Dr. Len Kitzes became acting chair of the Department of Anatomy and Neurobiology. When the IRU transitioned to CHR in 2005, Dr. Metherate was elected Director. Dr. Metherate joined UCI as an assistant professor in 1995, and currently is an associate professor in the Dept. of Neurobiology and Behavior. He is PI on two NIH R01 grants, from NIDCD and NIDA, and has maintained continuous funding from NIH and NSF for over 13 years to study cellular mechanisms in the auditory cortex. Since CHR is a UCI "Campus Center," its director reports directly to his own Dean (Biological Sciences) and the Vice Chancellor for Research, from whose office the mandate and funding for CHR originates. The line of communication with the Vice Chancellor for Research is important since the P30 and CHR involve faculty from eleven Departments in five Schools across the UCI campus. The P30 and CHR administrative structures are such that no single department carries undue weight or influence. (See the Appendix for a list of P30 faculty and their Department and School affiliations.) The P30 Executive Committee will comprise the Director, both Core Directors, and a rotating representative of the P30 investigators. Note that the Core Directors are from different Schools (Biological Sciences and Medicine). The Executive Committee will meet regularly, at least quarterly, to ensure that the needs of each Core and its users are met and that all facilities are being managed efficiently. Core Directors can voice concerns brought up at internal meetings of each Core's users and Advisory Committees. In addition, the Executive Committee as a group will solicit and evaluate feedback from all users at regular intervals, at least annually, and make recommendations to the Director for changes to P30 procedures and priorities. Important issues will include how the P30 is able to enhance ongoing research and promote interdisciplinary collaborations. Note that each Core director, in consultation with the Core's Advisory Committee, will be responsible for prioritizing usage of his or her core. In general, the highest priority for use of Core facilities will be to provide support for ongoing, R01-funded, NIDCD-related research. Secondary priority will be for research supported by other Federal funding (e.g., NIH-R03, NSF). Additional priorities (e.g., attracting new investigators to NIDCD-related topics) will be pursued when possible. Proper distribution of each Core's resources will be reviewed by the Executive Committee at quarterly meetings, and procedures to resolve inequities formulated. Administrative support for the P30 will be provided through Dr. Metherate's home department, the Dept. of Neurobiology and Behavior (Chair, Dr. Thomas J. Carew). Department staff will assist with personnel, purchasing, scheduling meetings, preparing progress reports and other administrative tasks. The department is familiar with the needs of interdisciplinary research centers, having a close relationship with three major research institutes directed by department faculty: the Center for the Neurobiology of Learning and Memory (Dr. Michael D. Rugg, Director), the Institute for Brain Aging and Dementia (Dr. Carl W. Cotman, Director), and the Reeve-Irvine Research Center (Dr. Oswald Steward, Director). Administrative effort for the P30 is expected to be minimal: 10% effort each for the Director and Core Directors, and 25% effort for an Administrative Assistant in the Dept. of Neurobiology and Behavior.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using nicotine to reverse age-related auditory processing deficits
  • 批准号:
    10543546
  • 项目类别:
  • 资助金额:
    $58.16万
  • 财政年份:
    2021
  • 负责人:
    Raju Metherate
  • 依托单位:
Using nicotine to reverse age-related auditory processing deficits
  • 批准号:
    10320043
  • 项目类别:
  • 资助金额:
    $60.07万
  • 财政年份:
    2021
  • 负责人:
    Raju Metherate
  • 依托单位:
Nicotinic enhancement of auditory-cognitive processing
  • 批准号:
    10056218
  • 项目类别:
  • 资助金额:
    $61.54万
  • 财政年份:
    2018
  • 负责人:
    Raju Metherate
  • 依托单位:
Nicotinic enhancement of auditory-cognitive processing
  • 批准号:
    10531234
  • 项目类别:
  • 资助金额:
    $60.62万
  • 财政年份:
    2018
  • 负责人:
    Raju Metherate
  • 依托单位:
海外基金